Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP)
ArchivedDARPA - Biological Technologies Office
Description
The goal of the FSHARP program is to leverage advances in bio-artificial blood substitute technologies to develop field deployable, shelf-stable hemorrhage countermeasures to sustain warfighters and civilian casualties in austere, pre-hospital settings.
Who can apply
- Others
Contact
BAA Coordinator<br/>HR001121S0027@darpa.mil
HR001121S0027@darpa.mil
Key dates & funding
- PostedMay 28, 2021
- ClosesAug 10, 2021
- CFDA12.910
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro